Carpmaels & Ransford LLP | European Union | 15 Mar 2024
In our previous article on IP and startup financing, we looked at the value that registered IP rights can bring to a startup. In this article, we…
Carpmaels & Ransford LLP | European Union | 13 Mar 2024
Multispecific antibodies can face many of the same patentability objections as monospecific antibodies, but their greater structural complexity gives…
Carpmaels & Ransford LLP | European Union | 1 Mar 2024
We reported in October 2023, that the EPO had overturned covid era guidance that allowed the use of e-signatures to execute assignments and other…
Carpmaels & Ransford LLP | European Union | 28 Feb 2024
Proposals to introduce centralised examination and unitary SPCs pass the first legislative hurdle The European Parliament has today approved…
Carpmaels & Ransford LLP | United Kingdom | 21 Feb 2024
The UKIPO’s refusal of Merck Serono’s UK SPC application for a new medical indication of cladribine has been upheld by the High Court but is set to…